rs1159327 — ESR1 ESR1 intron variant

Intronic variant in estrogen receptor alpha associated with bone mineral density; the T allele is linked to lower BMD and may influence ESR1 expression in bone and reproductive tissues

See your personal result for ESR1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

ESR1 Intron Variant — Estrogen Receptor Expression and Bone Health

The ESR1 gene encodes estrogen receptor alpha (ERα), the primary nuclear receptor through which estrogen orchestrates bone remodeling, reproductive function, and metabolism. ERα is expressed throughout the skeleton, uterus, ovary, breast, and cardiovascular system — making ESR1 variants some of the most broadly consequential polymorphisms in reproductive-age women. The rs1159327 variant sits deep within an ESR1 intron on chromosome 6 (position 151,726,887 GRCh38) and has been identified at genome-wide significance for bone mineral density11 identified at genome-wide significance for bone mineral density
He et al. Osteoporosis International 2023, n=141,261 UK Biobank participants, p=5×10⁻⁹.

The Mechanism

As an intronic variant, rs1159327 does not alter the ESR1 protein sequence. Instead, it likely influences gene expression through one of several regulatory mechanisms common to intronic SNPs: disruption of transcription factor binding sites22 transcription factor binding sites
protein complexes that bind DNA and control when and how much a gene is transcribed, alteration of enhancer activity, or effects on mRNA splicing efficiency. The ESR1 gene is large (~300 kb) with numerous regulatory elements distributed across its introns, and the intron 1 region in particular has been repeatedly implicated in controlling receptor expression levels.

ERα regulates osteoblast (bone-forming cell) proliferation and survival while suppressing osteoclast (bone-resorbing cell) activity. When ERα expression or sensitivity is reduced — as intronic regulatory variants can cause — the balance tips toward net bone resorption. The T allele at rs1159327 is associated with lower average bone mineral density, consistent with a model in which reduced ESR1 expression impairs estrogen's bone-protective signaling.

The Evidence

The primary evidence linking rs1159327 to bone health comes from a 2023 longitudinal GWAS in the UK Biobank33 2023 longitudinal GWAS in the UK Biobank
He et al., Osteoporosis International, n=141,261, which used trajectory analysis (TrajGWAS) to model heel bone mineral density over time. The ESR1 locus emerged at genome-wide significance (p=5×10⁻⁹) for BMD mean, placing rs1159327 among a handful of ESR1-region variants robustly associated with skeletal health in large populations.

This finding sits within a rich broader literature on the ESR1 locus. A meta-analysis of GWAS in premenopausal women44 A meta-analysis of GWAS in premenopausal women
Koller et al. JBMR 2013, discovery n=4,061 + replication n=5,597 identified multiple independent signals in the ESR1 region, and a separate GWAS in 2,468 European men55 a separate GWAS in 2,468 European men
Holliday et al. PLoS One 2011 confirmed the 6q25 locus affects both calcaneal ultrasound BMD and radial volumetric BMD. The largest early meta-analysis — 18,917 individuals across 8 European centers66 18,917 individuals across 8 European centers
Ioannidis et al. JAMA 2004 — found that ESR1 variants affect fracture risk by mechanisms independent of baseline bone density, suggesting the estrogen receptor pathway influences bone quality and geometry as well as mass.

Population data from dbSNP (ALFA) shows the T allele frequency varies from ~17% in South Asian populations to ~45% in African populations, meaning TT homozygosity (~8% globally) is substantially rarer in South/East Asian ancestry groups but more common in individuals of African descent.

Practical Implications

The most direct implications of the T allele relate to bone health across the lifespan. Carriers of one or two T alleles have a tendency toward lower bone mineral density, which translates to heightened importance of bone-protective behaviors — particularly weight-bearing exercise, calcium intake, vitamin D sufficiency, and proactive bone density monitoring. The effect of ESR1 variants on fracture risk appears to operate partly independently of BMD, which means a normal DEXA scan does not fully reassure against elevated fracture risk in T allele carriers.

For women, the ESR1 locus is also relevant to reproductive outcomes. Although the strongest fertility associations in ESR1 involve the nearby intron-1 variants rs2234693 (PvuII) and rs9340799 (XbaI), these three variants are in linkage disequilibrium and likely index overlapping biology. ESR1 polymorphisms have been examined in endometriosis, IVF outcomes, and ovarian reserve studies — the receptor's role in folliculogenesis, endometrial receptivity, and implantation means that even modest changes in expression can influence reproductive efficiency.

Interactions

rs1159327 sits near two of the most studied ESR1 variants: rs2234693 (PvuII, intron 1) and rs9340799 (XbaI, intron 1). These three variants span a regulatory stretch of ESR1 and are in partial linkage disequilibrium — meaning carriers of the rs1159327 T allele are more likely to also carry the rs2234693 T allele and rs9340799 G allele. Haplotype analyses of the ESR1 region show that combined effects on bone, cardiovascular, and hormone-responsive tissues can differ substantially from any single variant's individual contribution. Individuals carrying T alleles at multiple ESR1 loci may have more pronounced reductions in receptor expression.

Genotype Interpretations

What each possible genotype means for this variant.

CC Typical ESR1 Expression Normal

Common genotype associated with standard estrogen receptor activity and bone mineral density

You carry two copies of the reference C allele at rs1159327. About 52% of people globally share this genotype, making it the most common. Research associates CC with the higher end of the ESR1 expression range at this locus, which corresponds to typical estrogen receptor alpha activity in bone and reproductive tissues. Your bone mineral density risk from this variant is not elevated above the population baseline.

CT One T Allele Intermediate

One copy of the T allele associated with mildly reduced bone mineral density at the ESR1 locus

Intronic variants at ESR1 influence receptor expression rather than protein structure. The T allele at rs1159327 is thought to reduce ERα expression or alter splice efficiency in bone and reproductive tissues, tipping the balance of bone remodeling slightly toward resorption over formation. Evidence from the ESR1 locus more broadly suggests the effect on fracture risk can exceed what is predicted from BMD alone — the receptor modulates bone geometry and quality in addition to mineral density. As a heterozygous carrier you have one T allele and one protective C allele; the net effect is an additive partial shift toward the T-allele phenotype.

TT Two T Alleles Decreased

Two copies of the T allele associated with lower bone mineral density and potential reduction in ESR1 expression

The two T alleles at rs1159327 are expected to produce the greatest reduction in ESR1 expression or function at this locus, based on the additive inheritance pattern seen across ESR1 region variants. ERα (estrogen receptor alpha) is the primary estrogen effector in bone, driving osteoblast survival and limiting osteoclast activity. Reduced ERα expression means estrogen's bone-protective signaling is attenuated — the skeleton responds less robustly to circulating estrogen, resulting in net bone loss over time.

Evidence from the broader ESR1 literature (Ioannidis et al. JAMA 2004, 18,917 individuals) shows that ESR1 variant effects on fracture risk are partially independent of bone mineral density — suggesting the receptor also influences bone microarchitecture and geometry, which are not captured by standard DEXA.

The population frequency of TT varies substantially by ancestry: ~7% in Europeans and ~20% in Africans, reflecting different evolutionary selective pressures on the ESR1 locus. This means TT is a relatively uncommon but not rare genotype globally.

For women, ESR1 variants also influence reproductive tissue function through the same expression-level mechanism. The endometrium and ovarian follicles depend on ERα signaling for estrogen responsiveness; reduced receptor expression can affect endometrial receptivity and follicular maturation. The magnitude of this reproductive effect for rs1159327 specifically has not been characterized in IVF or endometriosis cohorts, but the biological mechanism is plausible given findings for nearby ESR1 intron-1 variants.